Adnan Said | Medicine | Best Researcher Award

Best Researcher Award

Adnan Said
University of Wisconsin School of Medicine and Public Health

Adnan Said
Affiliation University of Wisconsin School of Medicine and Public Health
Country United States
Scopus Id 35582909600
Documents 107
Citation 5,510
h-index 35
Subject Area Medicine
Event International Popular Scientist Awards
Orcid 0000-0001-9944-4071

Adnan Said is a medicine researcher affiliated with the University of Wisconsin School of Medicine and Public Health in the United States. The researcher profile supplied for this article lists 107 documents, 5,510 citations, and an h-index of 35 in Scopus, with research activity represented across hepatology, interventional radiology, liver transplantation, portal hypertension, and related clinical and translational areas. The publication record includes collaborative studies addressing transjugular intrahepatic portosystemic shunt (TIPS) procedures, gastrointestinal bleeding, liver fibrosis, and transplantation. [1]

Abstract

This academic recognition profile presents the research record of Adnan Said, whose supplied Scopus profile contains 107 documents, 5,510 citations, and an h-index of 35. His publication contributions represented in the supplied record focus substantially on liver-related clinical research, including portal hypertension, TIPS, gastrointestinal bleeding, liver transplantation, hepatic fibrosis, and associated diagnostic and therapeutic questions. The listed publications also demonstrate collaboration across multidisciplinary research groups involving hepatology, interventional radiology, transplantation, nuclear medicine, and related clinical sciences. [1]

Keywords

Adnan Said; Medicine; Hepatology; Liver Disease; Portal Hypertension; TIPS; Liver Transplantation; Gastrointestinal Bleeding; Liver Fibrosis; Interventional Radiology; Clinical Research; Translational Medicine; Research Impact.

Introduction

Research in hepatology and liver medicine encompasses complex interactions between chronic liver disease, portal hypertension, transplantation, vascular interventions, and complications such as gastrointestinal bleeding. Contemporary clinical investigation in these areas frequently combines patient outcomes, procedural variables, diagnostic imaging, and translational approaches. The publications supplied for this profile place Adnan Said within this multidisciplinary research environment, with several studies examining outcomes associated with TIPS and liver transplantation. [2]

Research Profile

The supplied bibliometric information identifies Adnan Said as a medicine researcher with a Scopus author identifier of 35582909600. The stated profile includes 107 documents, 5,510 citations, and an h-index of 35. These indicators describe the publication and citation record supplied for this recognition page and should be interpreted in the context of the coverage, indexing practices, author-disambiguation procedures, and update timing of the relevant database. [1]

The supplied publications demonstrate substantial collaborative authorship. The listed studies involve investigators from different clinical and research specialties and include multi-author ALTA Group investigations. Such collaboration is particularly relevant to complex liver-care research, where procedural outcomes, patient characteristics, imaging, transplantation, and clinical management may require integrated expertise.

Research Contributions

The supplied publications identify several recurring research themes. One area concerns outcomes following TIPS, a procedure used in the management of selected complications of portal hypertension. A 2025 ALTA Group study examined portal hypertensive gastropathy and MELD-Na score in relation to recurrent gastrointestinal bleeding after TIPS. [1]

Another contribution concerns changes in platelet count following TIPS creation. The 2023 study was conducted by the ALTA Group and investigated platelet-count changes after the procedure, contributing to the broader evaluation of physiological and clinical outcomes associated with TIPS. [2]

Publications

The following publications are drawn from the supplied Crossref-indexed publication information and represent selected research contributions associated with Adnan Said.

  1. Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics.
  2. Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology.
  3. The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology.
  4. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model. Journal of Nuclear Medicine.
  5. Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report. Transplant Infectious Disease.

Research Impact

The supplied Scopus metrics of 5,510 citations and an h-index of 35 provide bibliometric measures of the visibility and citation history associated with the identified author profile. [1] Bibliometric indicators are quantitative measures and do not independently establish the clinical effectiveness, methodological quality, or practical significance of individual studies.

Within the supplied publication sample, the research addresses clinically relevant questions concerning TIPS, portal hypertension, gastrointestinal bleeding, hemodynamic factors, liver fibrosis imaging, and transplantation. The combination of clinical studies, collaborative group research, and translational investigation indicates engagement with multiple dimensions of liver medicine. [1] [2] [3] [4] [5]

Award Suitability

For the purposes of the International Popular Scientist Awards, the supplied record provides several documented elements relevant to an academic recognition profile: a substantial indexed publication record, reported citation activity, an h-index of 35, and research contributions in medicine. The selected publications demonstrate work in liver-related clinical and translational research, including TIPS outcomes, portal hypertension, liver fibrosis imaging, and transplantation. [1]–[5]

Conclusion

Adnan Said’s supplied academic profile represents a research portfolio in medicine with notable emphasis on hepatology, liver-related interventions, transplantation, portal hypertension, and translational imaging. The stated Scopus record comprises 107 documents, 5,510 citations, and an h-index of 35. The selected publications further document participation in collaborative investigations addressing TIPS outcomes, gastrointestinal bleeding, platelet changes, hemodynamics, liver fibrosis, and transplantation. [1]–[5]

References

  1. Hu, K.; Sedki, M.; Kwong, A.; Kesselman, A.; Kolli, K. P.; Morelli, G.; Spengler, E.; Said, A.; Lai, J.; Desai, A.; et al. (2025). Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics.
    https://doi.org/10.1111/apt.18362
  2. Wong, R. J.; Ge, J.; Boike, J.; German, M.; Morelli, G.; Spengler, E.; Said, A.; Desai, A.; Couri, T.; Paul, S.; et al. (2023). Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology.
    https://doi.org/10.1016/j.jvir.2023.04.015
  3. Bommena, S.; Mahmud, N.; Boike, J. R.; Thornburg, B. G.; Kolli, K. P.; Lai, J. C.; German, M.; Morelli, G.; Spengler, E.; Said, A.; et al. (2023). The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology.
    https://doi.org/10.1097/HEP.0000000000000283
  4. Pirasteh, A.; Periyasamy, S.; Meudt, J. J.; Lui, Y.; Lee, L. M.; Schachtschneider, K. M.; Schook, L. B.; Gaba, R. C.; Mao, L.; Said, A.; et al. (2022). Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model. Journal of Nuclear Medicine.
    https://doi.org/10.2967/jnumed.121.263736
  5. Said, A.; Weiss, M.; Varhelyi, A.; Farago, R.; Ballweg, C.; Rice, J.; Agarwal, P.; Fernandez, L.; Foley, D. (2021). Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report. Transplant Infectious Disease.
    https://doi.org/10.1111/tid.13466
  6. Elsevier. (n.d.). Scopus author details: Adnan Said, Author ID 35582909600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35582909600

Fanny Lemarié | Medicine | Best Researcher Award

Best Researcher Award

Fanny Lemarié
Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, Brest, France

Fanny Lemarié
Affiliation Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest
Country France
Documents 2
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0009-0007-5938-7122

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, in Brest, France. Her documented research output includes two indexed documents in the field of Medicine. This academic profile presents her research background, scholarly contributions, publication record, potential research impact, and suitability for consideration for the Best Researcher Award within the International Popular Scientist Awards.

Abstract

This academic recognition profile presents Fanny Lemarié, a medical researcher based at the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The available profile records two research documents and identifies Medicine as the principal subject area. Her institutional setting places her scholarly activities within a specialized clinical environment concerned with hematology, hemostasis, and cancer-related medical research. The profile is intended to provide a structured scholarly overview rather than an independent assessment of research quality. Bibliographic information should be interpreted alongside authoritative researcher and publication databases. [1]

Keywords

Fanny Lemarié; Medicine; Hematology; Hemostasis; Cancer Research; Clinical Research; CHU de Brest; Brest; France; Medical Research.

Introduction

Clinical hematology and hemostasis are multidisciplinary areas of medicine that integrate laboratory investigation, diagnosis, patient management, and translational research. Research conducted in these settings can contribute to improved understanding of hematological disorders, coagulation processes, malignancies, treatment response, and patient-centered clinical care.[1]

Research Profile

The research profile of Fanny Lemarié is situated within Medicine and is institutionally connected to a specialized hematology and hemostasis service. The affiliation with the Institut de Cancéro-Hématologie further indicates a professional environment encompassing cancer-related hematological care and research. Such clinical research environments commonly involve interactions between laboratory medicine, hematology, oncology, diagnostic science, and therapeutic practice.

Research Contributions

The available information establishes a scholarly profile in Medicine with a focus connected to clinical hematology and hemostasis. Research conducted in this domain may support the characterization of hematological conditions, investigation of coagulation and bleeding disorders, evaluation of diagnostic approaches, and development or assessment of clinical strategies in hematology and oncology.[1]

Publications

The supplied academic profile records 2 documents for Fanny Lemarié. Complete publication titles, journal information, publication dates, author lists, citation counts, and DOI identifiers were not included in the source data provided for this article. Accordingly, individual publications are not listed here to avoid attributing bibliographic details without verification.[1]

Research Impact

Research impact in clinical medicine may be assessed through several complementary dimensions, including peer-reviewed publications, citations, methodological contributions, clinical translation, collaboration, educational activity, and contribution to evidence-based healthcare. For Fanny Lemarié, the available record confirms two research documents but does not provide verified citation or h-index values. Therefore, quantitative impact beyond the documented publication count cannot be responsibly stated from the supplied information.

Award Suitability

The Best Researcher Award is intended to recognize researchers whose scholarly activity demonstrates meaningful contributions to their respective fields. Based on the information supplied for this profile, Fanny Lemarié has a documented research presence in Medicine and is affiliated with a specialized clinical hematology and hemostasis service at CHU de Brest. These characteristics provide relevant professional context for consideration within a medical research award program.

Conclusion

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The supplied profile records two research documents and identifies Medicine as the relevant subject area. Her affiliation places her within a specialized clinical research setting focused on hematology, hemostasis, and cancer-related medicine. The available information supports consideration of her profile for academic recognition, while a comprehensive assessment should incorporate verified publication-level and bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Fanny Lemarié. Scopus. Bibliographic and author-profile information supplied for the academic recognition profile.
  2. ORCID. (n.d.). ORCID record for Fanny Lemarié. ORCID.
    https://orcid.org/0009-0007-5938-7122
  3. International Popular Scientist Awards. (n.d.). International Popular Scientist Awards.
    https://popularscientist.com/
  4. Lemarié, F., Picard, J., Galinat, H., Jaouen, S., Pan-Petesch, B., Nicol, C., Herbreteau, L., Civi, L., Rio, L., Lambert, W.-C., et al. (2026). Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome.